Secondary hyperparathyroidism is considered an important factor contributing to the degree of bone marrow fibrosis, which impairs the hematopoietic response and requires higher doses of EPO to achieve an adequate hematopoietic effect [11]. Here, EPO is linked to secondary hyperparathyroidism.